HEPION PHARMACEUTICALS, INC.

Company

Hepion Pharmaceuticals, Inc.

Filed

December 2, 2020

Accession Number

0000902664-20-004112

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →